Epacadostat
Showing 1 - 25 of 45
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)
Recruiting
- Metastatic Prostate Cancer
- +4 more
- M7824
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)
Completed
- Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Epacadostat 25 mg
- +7 more
- (no location specified)
Aug 17, 2022
Glioma, Glioblastoma Trial in United States (drug, radiation, procedure)
Recruiting
- Glioma
- Glioblastoma
- Epacadostat
- +4 more
-
Phoenix, Arizona
- +3 more
Oct 13, 2022
Rectal Cancer Trial in Orange, Detroit, Saint Louis (Epacadostat, Tumor biopsy, Peripheral blood draw)
Recruiting
- Rectal Cancer
- Epacadostat
- +2 more
-
Orange, California
- +2 more
Jul 6, 2022
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck
Terminated
- Metastatic Head and Neck Squamous Cell Carcinoma
- +2 more
- ImmunoPulse
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 1, 2022
Advanced Solid Tumors, Lymphoma Trial in Sacramento (epacadostat, SD-101, Radiotherapy)
Completed
- Advanced Solid Tumors
- Lymphoma
- epacadostat
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jan 25, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South
Withdrawn
- Esophageal Squamous Cell Carcinoma
- +2 more
- Epacadostat
- +3 more
-
Duarte, California
- +2 more
Feb 21, 2022
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Epacadostat
- +2 more
-
Minneapolis, Minnesota
- +1 more
Jan 27, 2023
Solid Tumors, Head Neck Cancer, Lung Cancer Trial in United States (MEDI4736, INCB024360)
Completed
- Solid Tumors
- +3 more
-
San Francisco, California
- +12 more
Jan 7, 2022
Gastrointestinal Stromal Tumors Trial in Ann Arbor, New York (Pembrolizumab, Epacadostat)
Completed
- Gastrointestinal Stromal Tumors
- Pembrolizumab
- Epacadostat
-
Ann Arbor, Michigan
- +1 more
Mar 18, 2021
Muscle-invasive Bladder Cancer Trial in Milan (Pembrolizumab, Epacadostat)
Withdrawn
- Muscle-invasive Bladder Cancer
- Pembrolizumab
- Epacadostat
-
Milan, ItalyFondazione IRCCS Istituto Nazionale Tumori
Feb 24, 2021
Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in Spain, United Kingdom, United States (Azacitidine,
Recurrent Epithelial Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Peritoneal Cancer Trial in Canada, United States
Active, not recruiting
- Recurrent Epithelial Ovarian Cancer
- +2 more
- DPX-Survivac
- +2 more
-
Palo Alto, California
- +8 more
Jun 16, 2021
Solid Tumor Trial in Baltimore (Epacadostat)
Terminated
- Solid Tumor
- Epacadostat
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 20, 2021
Head Neck Cancer Trial in Worldwide (Pembrolizumab, Epacadostat, Cetuximab)
Active, not recruiting
- Head and Neck Cancer
- Pembrolizumab
- +5 more
-
Anaheim, California
- +72 more
Jul 28, 2022
Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial (Durvalumab,
Withdrawn
- Epstein-Barr Virus Positive
- +6 more
- Durvalumab
- Epacadostat
- (no location specified)
Oct 22, 2020
Advanced Malignancies, Metastatic Cancer Trial in Los Angeles, Hackensack (INCAGN01876, Epacadostat, Pembrolizumab)
Terminated
- Advanced Malignancies
- Metastatic Cancer
- INCAGN01876
- +2 more
-
Los Angeles, California
- +1 more
Jul 1, 2021
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Renal Cell Carcinoma (RCC) Trial in Worldwide (Pembrolizumab, Epacadostat, Sunitinib)
Active, not recruiting
- Renal Cell Carcinoma (RCC)
- Pembrolizumab
- +3 more
-
Scottsdale, Arizona
- +139 more
Jun 3, 2022